5.050USD-6.65%Mkt Cap: 212.78M USDP/E: —Last update: 2026-06-01
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It …
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap212.78M USD
Enterprise Value13.18M USD
Revenue (TTM)127.48M USD
Gross Profit103.01M USD
Net Income (TTM)-38.94M USD
Revenue/Share3.105 USD
Last Price5.050 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees461
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.52
PEG—
EV/EBITDA-0.25
EV/Revenue0.10
P/S1.73
P/B0.80
EPS (TTM)-1.13
EPS (Forward)-0.56
52W Range
5.0500% of range16.36
52W High16.36 USD
52W Low5.050 USD
Profitability
Gross Margin76.60%
Oper. Margin-57.71%
EBITDA Margin-40.81%
Profit Margin-28.96%
ROE-14.13%
ROA-12.49%
Growth
Revenue Growth-18.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.51M USD
CapEx (TTM)3.83M USD
FCF Margin-0.76%
FCF Yield-0.46%
Net Debt-207.05M USD
Net Debt/EBITDA3.98
Balance Sheet
Debt/Equity0.04
Current Ratio10.20
Quick Ratio8.78
Book Value/Sh6.685 USD
Cash/Share5.263 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.1 (Hold)
Target (Mean)8.786 USD
Target Range7.500 USD – 11.00 USD
# Analysts7
Ownership
Shares Out.41.40M
Float39.18M
Insiders5.66%
Institutions93.25%
Short Interest
Short Ratio6.6d
Short % Float12.38%
Short % Out.11.72%
Shares Short4.85M
Short (prev mo.)5.57M
Technical
SMA 506.599 (-23.5%)
SMA 2008.635 (-41.5%)
Beta1.24
S&P 52W Chg27.70%
Avg Vol (30d)642.28K
Avg Vol (10d)641.01K
Technical Indicators
RSI (14)34.4
MACD-0.3244
MACD Signal-0.3027
MACD Hist.-0.0217
BB Upper7.347 USD
BB Middle6.083 USD
BB Lower4.819 USD
BB Width41.56%
ATR (14)0.3536 USD
Vol Ratio (20d)0.74x